Skip to main content
. 2023 Feb 23;30(3):2702–2714. doi: 10.3390/curroncol30030204

Table 4.

Survival rates.

N 5-Year OS
(SE)
5-Year DSS
(SE)
5-Year LRFS (SE) 5-Year DMFS (SE)
All patients 64 * 78.4% (6.7) 89% (4.9) 92.5% (3.6) 87.1% (4.5)

OS: overall survival; DSS: disease-specific survival; LRFS: local relapse-free survival; DMFS: distant metastasis-free survival; SE: standard error. * The patient treated for bilateral lesions was evaluated on the basis of the risk factors for the first lesion.